AllianceRx Walgreens Prime earns specialty pharmacy reaccreditation from URAC
ORLANDO, Fla., /PRNewswire/ -- AllianceRx Walgreens Prime, a specialty and home delivery pharmacy, received reaccreditation* from URAC for its specialty pharmacy services. URAC is the independent leader in promoting healthcare quality through accreditation, certification and measurement. By achieving this status, AllianceRx Walgreens Prime has demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes.
"Last spring, our home delivery pharmacies received accreditation from URAC, and I'm proud to announce our specialty pharmacies were just awarded full reaccreditation," says Joel Wright, chief executive officer of AllianceRx Walgreens Prime. "Receiving reaccreditation is affirmation of our teams' commitment to the highest standards of care for our patients."
URAC President and CEO Kylanne Green says URAC reaccreditation conveys that AllianceRx Walgreens Prime continues to adhere to industry best practices.
"It's necessary for specialty pharmacies to provide a higher level of treatment for patients so desired outcomes are achieved," she says. "AllianceRx Walgreens Prime shows a dedication to patient education and safety through the recognition of quality it received with URAC's independent accreditation."
The reaccreditation is effective until January 1, 2022.
* When searching URAC Directory of Accredited Organizations, AllianceRx Walgreens Prime's specialty pharmacy accreditation will be listed as Walgreens Specialty Pharmacy, LLC, and Prime Therapeutics Specialty Pharmacy LLC, parent organizations of the Orlando-based pharmacy.
About AllianceRx Walgreens Prime
View original content to download multimedia:http://www.prnewswire.com/news-releases/alliancerx-walgreens-prime-earns-specialty-pharmacy-reaccreditation-from-urac-300776867.html
SOURCE AllianceRx Walgreens Prime